Author:
Roy Soumyajit,Sayyid Rashid,Saad Fred,Sun Yilun,Lajkosz Katherine,Ong Michael,Klaassen Zachary,Malone Shawn,Spratt Daniel E.,Wallis Christopher J.D.,Morgan Scott C.
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference43 articles.
1. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015
2. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016
3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
4. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
5. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献